Mobia Medical, a company specializing in stroke recovery devices, announced its participation in the 8th Annual Wolfe Research Healthcare Conference on November 10, 2026. The management team will engage in a fireside chat and hold one-on-one investor meetings, highlighting their FDA-approved Vivistim® Paired VNS™ System designed to improve motor function in stroke survivors. This event offers investors insight into the company's innovative approach to stroke care and upcoming developments. A live webcast of the discussion will be available on Mobia Medical's website.
Mobia Medical's participation in the 8th Annual Wolfe Research Healthcare Conference provides context for readers interested in healthcare innovation. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 04:11 WIB: Out of 150 priced health-sector US stocks tradable on Pluang, 92 rose and 55 fell today. Notable movers include ACB at USD 5.16 with a 22.16% increase and Pluang order activity showing 62% Buy, NBIX at USD 165.00 with a 13.52% rise but 91% Sell activity, and INO at USD 1.65 down by 12.96% with a near even sell/buy split. The most notable figure is ACB's 22.16% gain.
Vencora has acquired CT InsureTech, a leading insurance technology provider with offices in London, Buenos Aires, and Mexico City. This acquisition strengthens Vencora's insurance technology offerings and expands its presence in Latin America and Eur...
Vencora has acquired CT InsureTech, a leading provider of insurance technology and services with offices in London, Buenos Aires, and Mexico City. This acquisition expands Vencora's portfolio and presence in Latin America and the UK, strengthening it...
SM Energy reported strong Q3 2026 results with $1.1 billion in operating cash flow, enabling $417 million in debt redemption and $133 million returned to shareholders through dividends and share buybacks. The company exceeded merger synergy targets a...
Freshworks Inc. reported strong Q3 2026 results with total revenue of $245.4 million, up 14% year-over-year, and GAAP net income of $18.3 million. The company achieved a 29% growth in adjusted free cash flow and maintained a 9-quarter streak of Rule ...
Treace Medical Concepts, a medical technology company specializing in surgical treatments for bunions and foot conditions, announced it will present at the Stifel 2026 Healthcare Conference on November 11, 2026. The company is known for its patented ...
